Martin Shkreli’s attempt to avoid public hearing is denied

Martin Shkreli, the former CEO of Turing Pharmaceuticals, was subpoenaed to appear at a public hearing on drug pricing on Jan. 26. Although he and his attorney tried to block the subpoena so Mr. Shkreli would not have to attend the hearing, that request was denied, according to The Hill.

Advertisement

The House Oversight and Government Reform Committee subpoenaed Mr. Shkreli Jan. 12, according to Bloomberg. If he doesn’t attend, the committee will pursue criminal charges.

Mr. Shkreli is taking every step to avoid attending the hearing. In a Jan. 22 letter, his attorney asked the House Oversight Committee to excuse Mr. Shkreli from attending and testifying due to a court order preventing him from leaving New York City, according to The Hill.

Mr. Shkreli also addressed his opinion via social media. According to Bloomberg, he Tweeted at lawmakers Jan. 22: “You want me to go to DC to just say ‘I plead the 5th’? For your entertainment?”

However, the leader of the committee — Rep. Jason Chaffetz (R-Utah) — denied the request. “We expect him to comply with our subpoena,” said a spokeswoman for Rep. Chaffetz, according to the report.

More articles on legal and regulatory issues:
Ex-operator of shuttered NC hospital to pay $148k in damages, fees
11 latest healthcare industry lawsuits, settlements
Medical billing company inks $500k false claims settlement

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.